Back to
Janus Henderson Group Ltd.
MAZE
5 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in Maze Therapeutics, Inc.
Yes. Janus Henderson holds 2,858,876 shares of MAZE (Maze Therapeutics), worth $85.3M, as of its Q1 2026 13F filing. It reduced the position by 283,711 shares (-9.0%) from Q4 2025. Janus Henderson has held MAZE in every 13F on record since Q1 2025, 5 quarterly filings.
Current Value
$85.3M
Current Shares
2.9M
Total Value Change
+$71M
Total Shares Change
+1.6M
Quarter-by-Quarter History
Other major holders of MAZE: BlackRock, Inc., Jupiter Topco LLC, Vanguard Group Inc.